Millennium's bugs

Article Abstract:

Millennium Pharmaceuticals has signed an agreement with Bayer, which is acquiring a stake of 14% in the company, set up in 1993 by Mark Levin. Levin is a chemical engineer and he has previously worked at Genetech and Miller Brewing, in process control. He is a generalist who has set up and run five companies in the biotech sector. He sees a need for continuous innovation and is prepared to buyin technology in order to keep abreast of new developments.

Millennium Pharmaceuticals Inc., MLNM

---

Genes and T-shirts: selling information rather than drugs is the key to making swift profits in biotechnology. Or so Kevin Kinsella believes

Article Abstract:

Former venture capitalist Kevin Kinsella has given up his investing activity in order to become a manager of Sequana Therapeutics, a biotechnology company. The company conducts an ongoing search for medically useful genes, and Kinsella owns a 4% stake.

Column, Kinsella, Kevin, Sequana Therapeutics Inc., SQWA

---

Smooth sailing, so far

Article Abstract:

The strategy of Ernesto Bertarelli at Serono is examined in detail, including the company's success in niche markets.

Pharmaceutical industry, Serono

Similar abstracts:

• Abstracts: Job shop scheduling with beam search. Analysis of reactive scheduling problems in a job shop environment. Optimal streaming of a single job in a two-stage flow shop
• Abstracts: Bush's possible win doesn't minimize shift in senate. U.K.'s former Chancellor is new Tory favorite. Uncool Britannia
• Abstracts: Planning market share growth in mature business markets. Emerging technologies for enhancing supplier-reseller partnerships
• Abstracts: Product liability cost as a marketing tool. Specifying and synchronizing partner activities in the dispersed product development process
• Abstracts: Textile washing products. Household cleaning products in Western Europe. Skin care in Germany

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.